{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:07:47Z","timestamp":1776254867367,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Military Logistics Research Project","award":["23JSZ11"],"award-info":[{"award-number":["23JSZ11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-04183-5","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:55:28Z","timestamp":1773046528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a novel rabbit auricle xenograft model of human PC3 prostate cancer"],"prefix":"10.1186","volume":"31","author":[{"given":"Xilong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"1","key":"4183_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4183_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","volume":"87","author":"EJ Schafer","year":"2025","unstructured":"Schafer EJ, Laversanne M, Sung H, et al. Recent patterns and trends in global prostate cancer incidence and mortality: an update. Eur Urol. 2025;87(3):302\u201313.","journal-title":"Eur Urol"},{"issue":"3","key":"4183_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4183_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RC, Briers E. EAU-EANM-ESTRO-ESUR-ISUP SIOG guidelines on prostate cancer\u20142024 update. Part I: screening diagnosis and local treatment with curative intent. Eur Urol. 2024;86(2):148\u201363.","journal-title":"Eur Urol"},{"issue":"2","key":"4183_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki D, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II\u20142024 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2024;86(2):164\u201382.","journal-title":"Eur Urol"},{"key":"4183_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122469","author":"R Hu","year":"2024","unstructured":"Hu R, Lan J, Zhang D, Shen W. Nanotherapeutics for prostate cancer treatment: a comprehensive review. Biomaterials. 2024. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122469.","journal-title":"Biomaterials"},{"issue":"9","key":"4183_CR7","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00270-022-03165-4","volume":"45","author":"I Insausti","year":"2022","unstructured":"Insausti I, Galbete A, Lucas-Cava V, et al. Prostatic artery embolization (PAE) using polyethylene glycol microspheres: safety and efficacy in 81 patients. Cardiovasc Intervent Radiol. 2022;45(9):1339\u201348.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"4183_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jvir.2019.12.810","volume":"31","author":"I Insausti","year":"2020","unstructured":"Insausti I, S\u00e1ez de Oc\u00e1riz A, Galbete A, et al. Randomized comparison of prostatic artery embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2020;31(6):882\u201390.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"4183_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/bju.13147","volume":"117","author":"M Wang","year":"2015","unstructured":"Wang M, Guo L, Duan F, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium\u2010 and large\u2010volume prostates. BJU Int. 2015;117(1):155\u201364.","journal-title":"BJU Int"},{"issue":"4","key":"4183_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.21037\/tau-22-189","volume":"11","author":"Y Guan","year":"2022","unstructured":"Guan Y, Wang W, Zhang T, et al. Epirubicin-loaded beads transarterial prostatic arterial chemoembolization is a promising treatment for advanced prostate cancer with lower urinary tract obstruction or hematuria\u2014a case series report. Transl Androl Urol. 2022;11(4):480\u201394.","journal-title":"Transl Androl Urol"},{"key":"4183_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9750795","volume":"2016","author":"D Rea","year":"2016","unstructured":"Rea D, del Vecchio V, Palma G, et al. Mouse models in prostate cancer translational research: from xenograft to PDX. BioMed Res Int. 2016;2016:1\u201311.","journal-title":"BioMed Res Int"},{"issue":"3","key":"4183_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41585-022-00677-z","volume":"20","author":"V Sailer","year":"2022","unstructured":"Sailer V, von Amsberg G, Duensing S, et al. Experimental in vitro, ex\u00a0vivo and in vivo models in prostate cancer research. Nat Rev Urol. 2022;20(3):158\u201378.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"4183_CR13","first-page":"169","volume":"11","author":"EA Gibson","year":"2024","unstructured":"Gibson EA, Culp WTN. Canine prostate cancer: current treatments and the role of interventional oncology. Vet Sci. 2024;11(4):169.","journal-title":"Vet Sci"},{"issue":"1","key":"4183_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.21873\/anticanres.16167","volume":"43","author":"AI Faustino-Rocha","year":"2023","unstructured":"Faustino-Rocha AI, Jota-Baptista C, Nascimento-Gon\u00c7Alves E, Oliveira PA. Evolution of models of prostate cancer: their contribution to current therapies. Anticancer Res. 2023;43(1):323\u201333.","journal-title":"Anticancer Res"},{"key":"4183_CR15","volume-title":"Patient-derived xenografts","author":"LK Philp","year":"2024","unstructured":"Philp LK. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development. In: Patient-derived xenografts. New York: Springer; 2024."},{"key":"4183_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.lfs.2018.04.014","volume":"203","author":"E Nascimento-Gon\u00e7alves","year":"2018","unstructured":"Nascimento-Gon\u00e7alves E, Faustino-Rocha AI, Seixas F, et al. Modelling human prostate cancer: rat models. Life Sci. 2018;203:210\u201324.","journal-title":"Life Sci"},{"issue":"3","key":"4183_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.21037\/tau.2017.03.61","volume":"6","author":"F Sun","year":"2017","unstructured":"Sun F, B\u00e1ez-D\u00edaz C, S\u00e1nchez-Margallo FM. Canine prostate models in preclinical studies of minimally invasive interventions: part I, canine prostate anatomy and prostate cancer models. Transl Androl Urol. 2017;6(3):538\u201346.","journal-title":"Transl Androl Urol"},{"issue":"9","key":"4183_CR18","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/pros.22642","volume":"73","author":"JM Keller","year":"2013","unstructured":"Keller JM, Schade GR, Ives K, et al. A novel canine model for prostate cancer. Prostate. 2013;73(9):952\u20139.","journal-title":"Prostate"},{"key":"4183_CR19","unstructured":"National Research Council Committee for the Update of the Guide for the C, Use of Laboratory A. The National Academies Collection: Reports funded by National Institutes of Health. In: Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US)Copyright \u00a9 2011, National Academy of Sciences.; 2011."},{"key":"4183_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/394730","author":"SJ Kang","year":"2010","unstructured":"Kang SJ, Grossniklaus HE, Fedele M. Rabbit Model of Retinoblastoma. BioMed Res Int. 2010. https:\/\/doi.org\/10.1155\/2011\/394730.","journal-title":"BioMed Res Int"},{"issue":"2","key":"4183_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jvir.2014.09.002","volume":"26","author":"S Hamamoto","year":"2015","unstructured":"Hamamoto S, Okuma T, Yamamoto A, et al. Combination radiofrequency ablation and local injection of the immunostimulant Bacillus Calmette\u2013Gu\u00e9rin induces antitumor immunity in the lung and at a distant VX2 tumor in a rabbit model. J Vasc Interv Radiol. 2015;26(2):271\u20138.","journal-title":"J Vasc Interv Radiol"},{"key":"4183_CR22","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00960-4","author":"EM Tosca","year":"2024","unstructured":"Tosca EM, Ronchi D, Rocchetti M, Magni P. Predicting tumor volume doubling time and progression-free survival in untreated patients from patient-derived-xenograft (PDX) models: a translational model-based approach. AAPS J. 2024. https:\/\/doi.org\/10.1208\/s12248-024-00960-4.","journal-title":"AAPS J"},{"issue":"1","key":"4183_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00330-022-08966-2","volume":"33","author":"N Sadeghipour","year":"2022","unstructured":"Sadeghipour N, Tseng J, Anderson K, et al. Tumor volume doubling time estimated from digital breast tomosynthesis mammograms distinguishes invasive breast cancers from benign lesions. Eur Radiol. 2022;33(1):429\u201339.","journal-title":"Eur Radiol"},{"key":"4183_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316282","author":"Z Huang","year":"2025","unstructured":"Huang Z, Choi W, Kwak BK, et al. Feasibility of rabbit auricular VX2 tumor model as an experimental model for intra-arterial embolization. PLoS ONE. 2025. https:\/\/doi.org\/10.1371\/journal.pone.0316282.","journal-title":"PLoS ONE"},{"key":"4183_CR25","doi-asserted-by":"publisher","DOI":"10.4103\/1735-3327.92960","author":"B Thomas","year":"2012","unstructured":"Thomas B, Bhat KM, Mapara M. Rabbit as an animal model for experimental research. Dent Res J Isfahan. 2012. https:\/\/doi.org\/10.4103\/1735-3327.92960.","journal-title":"Dent Res J Isfahan"},{"issue":"2","key":"4183_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1148\/radiol.13120249","volume":"267","author":"S Hamamoto","year":"2013","unstructured":"Hamamoto S, Okuma T, Yamamoto A, et al. Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits. Radiology. 2013;267(2):405\u201313.","journal-title":"Radiology"},{"issue":"5","key":"4183_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1054\/jcms.2000.0165","volume":"28","author":"RJJ van Es","year":"2000","unstructured":"van Es RJJ, Dullens HFJ, van der Bilt A, Koole R, Slootweg PJ. Evaluation of the VX2 rabbit auricle carcinoma as a model for head and neck cancer in humans. J Craniomaxillofac Surg. 2000;28(5):300\u20137.","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"4183_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41391-022-00516-7","volume":"26","author":"MQ Wang","year":"2022","unstructured":"Wang MQ, Zhang JL, Duan F, et al. Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer. Prostate Cancer Prostatic Dis. 2022;26(1):88\u201395.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"4183_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.diii.2021.07.003","volume":"102","author":"O Pellerin","year":"2021","unstructured":"Pellerin O, D\u00e9an C, Reb P, et al. Prostate artery chemoembolization in prostate cancer: a proof of concept study in spontaneous prostate cancer in a canine model. Diagn Interv Imaging. 2021;102(12):709\u201315.","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"4183_CR30","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/jvim.12594","volume":"29","author":"WTN Culp","year":"2015","unstructured":"Culp WTN, Weisse C, Berent AC, et al. Early tumor response to intraarterial or intravenous administration of carboplatin to treat naturally occurring lower urinary tract carcinoma in dogs. J Vet Intern Med. 2015;29(3):900\u20137.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"4183_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/pros.24314","volume":"82","author":"Y Wang","year":"2022","unstructured":"Wang Y, Abenojar EC, Wang J, et al. Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit. Prostate. 2022;82(6):695\u2013705.","journal-title":"Prostate"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-04183-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:22:44Z","timestamp":1776252164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-04183-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4183"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-04183-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Approval for this experiment was granted by the Experimental Animal Welfare and Ethics Committee of the Chinese PLA General Hospital (No. EAC-IACUC-2025F21-077), ensuring adherence to the guidelines outlined in the Guide for the Care and Use of Laboratory Animals. Euthanasia was carried out under profound anesthesia via intramuscular injection of a mixture of tiletamine\/zolazepam (10 mg\/kg) and xylazine (4 mg\/kg), followed by an intravenous injection of potassium chloride (2 mg\/kg) to minimize distress.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"563"}}